1. Extra-intestinal pathogenic Escherichia coli - threat connected with food-borne infections;Wasiński;Ann. Agric. Environ. Med.,2019
2. Proteomic analysis of Escherichia coli associated with urinary tract infections;Smith;Proteomics,2011
3. A.V. Page, W.C. Liles, Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome, Med Clin North Am 97(4) (2013) 681-95, xi.
4. Omadacycline for Acute Bacterial Skin and Skin Structure Infections;Abrahamian;Clin. Infect. Dis.,2019
5. B. François, H.S. Jafri, J. Chastre, M. Sánchez-García, P. Eggimann, P.F. Dequin, V. Huberlant, L. Viña Soria, T. Boulain, C. Bretonnière, J. Pugin, J. Trenado, A.C. Hernandez Padilla, O. Ali, K. Shoemaker, P. Ren, F.E. Coenjaerts, A. Ruzin, O. Barraud, L. Timbermont, C. Lammens, V. Pierre, Y. Wu, J. Vignaud, S. Colbert, T. Bellamy, M.T. Esser, F. Dubovsky, M.J. Bonten, H. Goossens, P.F. Laterre, Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial, Lancet Infect Dis 21(9) (2021) 1313-1323.